Sensorium Therapeutics
Abriel Markowitz is a Senior Research Associate at Sensorium Therapeutics. Prior to this role, Abriel worked as an Associate Scientist at Pharmaron US Lab Services and as a Research Intern at Thuvakkam NGO. Abriel also has experience as a Genetic Testing Research Assistant at Nutritional Counseling. Abriel graduated from Michigan State University with a degree in Integrative Biology focusing on Genomics and Molecular Genetics.
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.